Literature DB >> 31988391

B cells, plasma cells and antibody repertoires in the tumour microenvironment.

George V Sharonov1,2,3, Ekaterina O Serebrovskaya2,3, Diana V Yuzhakova1, Olga V Britanova1,2,3, Dmitriy M Chudakov4,5,6,7.   

Abstract

Recent data show that B cells and plasma cells located in tumours or in tumour-draining lymph nodes can have important roles in shaping antitumour immune responses. In tumour-associated tertiary lymphoid structures, T cells and B cells interact and undergo cooperative selection, specialization and clonal expansion. Importantly, B cells can present cognate tumour-derived antigens to T cells, with the functional consequences of such interactions being shaped by the B cell phenotype. Furthermore, the isotype and specificity of the antibodies produced by plasma cells can drive distinct immune responses. Here we summarize our current knowledge of the roles of B cells and antibodies in the tumour microenvironment. Moreover, we discuss the potential of using immunoglobulin repertoires as a source of tumour-specific receptors for immunotherapy or as biomarkers to predict the efficacy of immunotherapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31988391     DOI: 10.1038/s41577-019-0257-x

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  196 in total

1.  Identification of T and B lymphocytes in human breast cancer with immunohistochemical techniques.

Authors:  R Schoorl; A B Riviere; A E Borne; T M Feltkamp-Vroom
Journal:  Am J Pathol       Date:  1976-09       Impact factor: 4.307

2.  Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.

Authors:  Marie-Caroline Dieu-Nosjean; Martine Antoine; Claire Danel; Didier Heudes; Marie Wislez; Virginie Poulot; Nathalie Rabbe; Ludivine Laurans; Eric Tartour; Luc de Chaisemartin; Serge Lebecque; Wolf-Herman Fridman; Jacques Cadranel
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

3.  Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade.

Authors:  Spencer C Wei; Jacob H Levine; Alexandria P Cogdill; Yang Zhao; Nana-Ama A S Anang; Miles C Andrews; Padmanee Sharma; Jing Wang; Jennifer A Wargo; Dana Pe'er; James P Allison
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

Review 4.  CD4+ T cell help in cancer immunology and immunotherapy.

Authors:  Jannie Borst; Tomasz Ahrends; Nikolina Bąbała; Cornelis J M Melief; Wolfgang Kastenmüller
Journal:  Nat Rev Immunol       Date:  2018-10       Impact factor: 53.106

Review 5.  Molecular and cellular insights into T cell exhaustion.

Authors:  E John Wherry; Makoto Kurachi
Journal:  Nat Rev Immunol       Date:  2015-08       Impact factor: 53.106

6.  Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.

Authors:  Khalid I Al-Shibli; Tom Donnem; Samer Al-Saad; Magnus Persson; Roy M Bremnes; Lill-Tove Busund
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

7.  Lymphocyte subset infiltration patterns and HLA antigen status in colorectal carcinomas and adenomas.

Authors:  P A Jackson; M A Green; C G Marks; R J King; R Hubbard; M G Cook
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

8.  Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.

Authors:  Gabriela Bindea; Bernhard Mlecnik; Marie Tosolini; Amos Kirilovsky; Maximilian Waldner; Anna C Obenauf; Helen Angell; Tessa Fredriksen; Lucie Lafontaine; Anne Berger; Patrick Bruneval; Wolf Herman Fridman; Christoph Becker; Franck Pagès; Michael R Speicher; Zlatko Trajanoski; Jérôme Galon
Journal:  Immunity       Date:  2013-10-17       Impact factor: 31.745

Review 9.  Neoantigens in cancer immunotherapy.

Authors:  Ton N Schumacher; Robert D Schreiber
Journal:  Science       Date:  2015-04-03       Impact factor: 47.728

10.  An Immune Atlas of Clear Cell Renal Cell Carcinoma.

Authors:  Stéphane Chevrier; Jacob Harrison Levine; Vito Riccardo Tomaso Zanotelli; Karina Silina; Daniel Schulz; Marina Bacac; Carola Hermine Ries; Laurie Ailles; Michael Alexander Spencer Jewett; Holger Moch; Maries van den Broek; Christian Beisel; Michael Beda Stadler; Craig Gedye; Bernhard Reis; Dana Pe'er; Bernd Bodenmiller
Journal:  Cell       Date:  2017-05-04       Impact factor: 41.582

View more
  121 in total

1.  Lipid Metabolism in Tumor-Associated B Cells.

Authors:  Fan Yang; Fang Wan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Autophagy in tumour immunity and therapy.

Authors:  Houjun Xia; Douglas R Green; Weiping Zou
Journal:  Nat Rev Cancer       Date:  2021-03-23       Impact factor: 60.716

Review 3.  Informing the new developments and future of cancer immunotherapy : Future of cancer immunotherapy.

Authors:  Atul Kumar; Courtney A Swain; Lalita A Shevde
Journal:  Cancer Metastasis Rev       Date:  2021-05-18       Impact factor: 9.264

4.  Key Candidate Genes - VSIG2 of Colon Cancer Identified by Weighted Gene Co-Expression Network Analysis.

Authors:  Zhongze Cui; Yangyang Li; Shuang He; Feifei Wen; Xiaoyang Xu; Lizhen Lu; Shuhua Wu
Journal:  Cancer Manag Res       Date:  2021-07-15       Impact factor: 3.989

Review 5.  Effective high-throughput isolation of fully human antibodies targeting infectious pathogens.

Authors:  Lutz Gieselmann; Christoph Kreer; Meryem Seda Ercanoglu; Nathalie Lehnen; Matthias Zehner; Philipp Schommers; Julian Potthoff; Henning Gruell; Florian Klein
Journal:  Nat Protoc       Date:  2021-05-25       Impact factor: 13.491

Review 6.  B cell heterogeneity, plasticity, and functional diversity in cancer microenvironments.

Authors:  Yuan Wei; Chun-Xiang Huang; Xiao Xiao; Dong-Ping Chen; Hong Shan; Huanhuan He; Dong-Ming Kuang
Journal:  Oncogene       Date:  2021-06-29       Impact factor: 9.867

Review 7.  Cancer stem cell-immune cell crosstalk in tumour progression.

Authors:  Defne Bayik; Justin D Lathia
Journal:  Nat Rev Cancer       Date:  2021-06-08       Impact factor: 60.716

8.  Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1-Dependent Myeloid Cells.

Authors:  E Kaitlynn Allen; Jeremy Chase Crawford; Lee-Ann Van de Velde; Taylor L Wilson; Clifford S Guy; Marion Russier; Leonie Zeitler; Armita Bahrami; David Finkelstein; Stephane Pelletier; Stacey Schultz-Cherry; Paul G Thomas; Peter J Murray
Journal:  Cancer Res       Date:  2021-07-23       Impact factor: 12.701

9.  A comprehensive analysis of tumor microenvironment-related genes in colon cancer.

Authors:  R Luo; W Guo; H Wang
Journal:  Clin Transl Oncol       Date:  2021-03-10       Impact factor: 3.405

Review 10.  Regulatory B cells in cancer.

Authors:  Daniel Michaud; Colleen R Steward; Bhalchandra Mirlekar; Yuliya Pylayeva-Gupta
Journal:  Immunol Rev       Date:  2020-12-23       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.